Protein and creatine during menopause: what the evidence supports

There is no separate New Zealand protein RDI simply because someone is in perimenopause or postmenopause. Age, current food intake, training, health, energy intake and the goal all affect the decision. Start by making the training and meals workable; then decide whether either supplement has a clear job.

This guide does not cover menopausal hormone therapy or advise on medicines. New or severe symptoms, bleeding after 12 months without a period, bleeding between periods, unexplained weight change, marked weakness or concern about bone health require appropriate clinical assessment.

Separate three questions that marketing often mixes together

Protein and creatine decisions may sit within a healthy routine, but neither should be marketed as treating the menopause transition. Keep symptom care, bone-health assessment and sports nutrition as separate decisions.

Begin with training and food

Health New Zealand recommends being active on most days and completing at least two muscle-strengthening sessions each week as part of living well through menopause. It also recommends a high-quality diet rich in whole foods. Health NZ menopause guidance[1]

That is a starting frequency, not a programme for every person. Exercise selection, load, range of motion and progression should fit training experience, pain, pelvic-floor symptoms, balance, injury history and bone health. A person new to lifting does not need to copy an experienced athlete's programme.

A simple food-first review asks:

1. Are meals regular enough to support the day and training?
2. Does each main meal contain a recognisable protein food?
3. Are energy intake and food variety adequate, rather than being displaced by “clean eating” rules or supplements?
4. Are time, appetite, cost, cooking access or symptoms making food difficult?
5. What exact gap would a powder solve?

Protein foods can include dairy foods, eggs, fish, meat, soy foods, legumes, nuts and seeds, depending on dietary pattern and allergies. A powder is another food format; consider whether it fills a gap in those meals.

For help adapting meals to your food preferences and needs, see Inception Nutrition. Check the qualifications and scope of the professional you choose; medical conditions and significant nutrition risk call for a registered dietitian or clinical team.

How much protein is relevant?

The Australia and New Zealand Nutrient Reference Values list an RDI for women aged 19–70 of 46 g/day, or 0.75 g/kg/day, and for women over 70 of 57 g/day, or 0.94 g/kg/day. These are population reference values for generally healthy people. They are not a menopause-specific muscle-building prescription. Australia and New Zealand protein reference values[3]

Sports and healthy-ageing papers often discuss higher intakes, but an internet grams-per-kilogram figure should not be applied automatically. The appropriate number may change with training, energy restriction, body size and illness. Kidney disease, a history of disordered eating, substantial weight loss or a clinical diet plan requires individual advice.

If you have an agreed target, review ordinary food first. Estimate several representative days rather than one unusually good or poor day. Then fill only the remaining gap. The worked calculations in how much protein per day show how to distinguish a population reference value from an individual plan.

Does timing matter more than the total?

Most practical plans begin with an adequate daily pattern and regular protein-containing meals. Timing a supplement to the minute is a lower-priority question if breakfast contains little food, lunch is regularly missed or total intake is inadequate.

If training ends near a normal meal, that meal may already serve the purpose. If food is unavailable or difficult to tolerate, a shake can offer convenience. The decision depends on the whole serving and day, not a narrow “anabolic window” claim.

Calcium: food or supplement after menopause?

Start by estimating calcium from ordinary food rather than assuming every postmenopausal woman needs a tablet. The Australia and New Zealand Nutrient Reference Values list an RDI of 1,000 mg/day for women aged 19–50 and 1,300 mg/day for women aged 51 and older; the rationale also identifies 1,300 mg/day for postmenopausal women. These are total-intake reference values, not supplement doses. Australia and New Zealand calcium reference values[4]

Health New Zealand says it is safer and more effective to obtain calcium from the diet than to rely on supplements, and that strong evidence that calcium supplements prevent fractures is lacking. It recommends a varied diet with calcium-rich foods and individual bone-risk assessment. Health NZ osteoporosis guidance[2]

These examples show where to look; they are not a prescribed menu. If intake appears low, a registered dietitian can help calculate the actual gap. A clinician or pharmacist should decide whether a supplement is appropriate, particularly with kidney stones, kidney disease, high blood calcium, osteoporosis medicines, thyroid medicine, iron or other interacting products. A supplement should fill an assessed gap rather than be added on top of an unknown total, and it should not be promoted as a fracture-prevention guarantee.

For current New Zealand food examples, see Health NZ: eating well for healthy bones[5].

What direct protein trials in postmenopausal women found

Menopause-specific studies are useful because they reduce the need to extrapolate from young men, but they are generally small and short. Their supplement protocols should be read as study methods, not universal instructions.

Sources: Weisgarber and colleagues, 2015[6], Nahas and colleagues, 2019[7], and Ioannidou and colleagues, 2024[8].

These trials do not show that extra protein never helps. They show why “menopause requires this shake” is too strong. Starting intake, training stimulus, adherence, total energy and outcome choice all affect whether a supplement produces a measurable additional result.

An acute experiment after five days of severe energy restriction found a greater short-term muscle-protein-synthesis response after 35 g or 60 g whey than after 15 g in overweight postmenopausal women. It measured tracer-derived synthesis over hours, not long-term strength, function or safety, and its restrictive diet is not a routine eating plan. It should not be turned into a general 35 g-per-meal prescription. Acute whey dose-response study[9]

What creatine research in postmenopausal women shows

Creatine helps recycle energy rapidly in muscle. That mechanism makes it relevant to repeated high-effort exercise, but a plausible mechanism does not prove every promoted menopause outcome.

A 2026 systematic review pooled seven placebo-controlled trials with 608 randomised postmenopausal women. Across five trials, creatine was associated with an average 0.37 kg greater lean mass, with a 95% confidence interval from 0.05 to 0.69 kg and a prediction interval from -0.10 to 0.84 kg. Across three trials, the average leg-press difference was 7.5 kg. Bone mineral density was unchanged overall. Most trials had “some concerns” for risk of bias, and the review was not prospectively registered. 2026 systematic review[10]

The review's subgroup results appeared more favourable when at least 5 g/day was combined with resistance training. That is a research observation across a small set of trials, not a rule that everyone in menopause should take 5 g. Prediction intervals and the number of contributing trials show that an individual's result may differ from the pooled average.

The largest long trial did not improve bone mineral density

In a two-year trial, 237 postmenopausal women with a mean age of 59 were assigned creatine at 0.14 g/kg/day or placebo while undertaking resistance training three days a week and walking six days a week. Creatine did not improve bone mineral density at the femoral neck, total hip or lumbar spine. It maintained two femoral-neck geometry measures relative to placebo, but those surrogate measures are not fractures and do not justify an osteoporosis-prevention claim. Chilibeck and colleagues, 2023[11]

“Studied in a bone-health trial” and “prevents osteoporosis” are not equivalent statements. If fracture risk or bone loss is the concern, use Health NZ's osteoporosis information and seek an appropriate clinical assessment. Health NZ osteoporosis guidance[2]

Evidence from older women is supportive context, not automatically menopause evidence

Some creatine and protein studies enrol older women without making the menopause transition the scientific question. They can inform healthy-ageing discussions but should be labelled as indirect evidence when menopause status or symptoms are not central to eligibility and analysis.

For example, a 24-week trial in 60 vulnerable older women studied creatine and resistance training in four groups. Creatine plus training improved some measures compared with control conditions, while not every strength or bone outcome differed from training plus placebo. This is relevant older-adult evidence; it does not demonstrate treatment of menopause. Gualano and colleagues, 2014[12]

Should you use protein powder, creatine, both or neither?

If both products are being considered, evaluate them separately. Protein powder should have a demonstrated intake or convenience job. Creatine should have a training-related goal and realistic expectations. A “menopause stack” bundles distinct decisions and makes it harder to see whether either product adds value.

How to assess a protein powder

Check the current label rather than relying on category assumptions:

• grams of protein per actual serving, not powder weight;
• serving directions and number of servings;
• protein source and whether it fits dietary preferences;
• milk, soy and other allergen declarations;
• ingredients that may affect tolerance;
• cost per serving that supplies the intended amount; and
• what the powder is mixed with.

Whey, soy and other plant proteins can all fit different diets. Collagen has a different amino-acid profile and should not be assumed to replace a complete protein powder gram for gram in a muscle-focused plan. See whey, plant and collagen protein.

How to assess creatine without buying the strongest story

Start with the ingredient. Most performance research uses creatine monohydrate. A proprietary “women's” or “menopause” blend is not made more effective by extra claims, and research on one form cannot automatically substantiate another.

Then check:

• creatine monohydrate amount per serving;
• whether a scoop has a stated weight and can be measured reliably;
• full ingredients, allergens and stimulant content;
• batch or third-party testing evidence if sport rules matter;
• cost per comparable amount; and
• whether the retailer distinguishes study protocols from personal advice.

Creatine can increase measured body weight in some people as water is retained with stored creatine. That is not the same as fat gain, but it may still matter to someone for whom scale changes are distressing. A detailed evidence and label discussion is available in the creatine monohydrate guide.

Safety and referral boundaries

Healthy adult trials are reassuring overall, but a shop page cannot clear an individual for a supplement. Speak with a clinician or pharmacist before using creatine when kidney disease, unexplained abnormal kidney results, complex medicines or another medical condition changes the decision. Tell the person ordering blood tests that you take creatine, because interpretation belongs in clinical context.

Seek individual nutrition advice when appetite is persistently low, food groups are heavily restricted, weight changes unexpectedly, gastrointestinal symptoms interfere with eating, or a medical condition affects protein, fluids or electrolytes. Avoid aggressive energy restriction to pursue a body-composition promise during a time when adequate food and progressive training need to be sustainable.

For a training plan suited to your experience and health context, see Inception Gym. Check that the coach's qualifications and scope fit your needs; clinical symptoms, injury rehabilitation and osteoporosis management require the relevant health professional.

Common questions

Do women need more protein as soon as perimenopause starts?

New Zealand reference values do not set a separate perimenopause RDI. Needs and useful targets depend on age, training, energy intake, body size, health and current intake. Review the whole diet before assigning a supplement.

Is whey better than food after menopause?

Whey is convenient and has been studied, but direct trials do not establish that it is superior to an adequate food pattern for every postmenopausal woman. The practical comparison includes the whole meal, tolerance, dietary preference and whether there is a real gap.

Does creatine prevent bone loss after menopause?

That claim is not established. The largest two-year trial did not improve bone mineral density at the main sites, and the current pooled analysis found bone density unchanged overall. Bone geometry findings are research signals, not evidence of fracture prevention.

Does creatine help menopause brain fog?

The muscle and training trials discussed here do not answer that question. Small emerging studies using different creatine forms and cognitive outcomes should not be converted into a treatment claim. Discuss persistent cognitive or mood changes with a clinician who can assess other causes.

Can protein and creatine be mixed together?

The more important question is whether each is appropriate and has a defined role. Mixing them does not make an inadequate diet complete or replace training. Follow current product directions and individual professional advice.

A practical sequence

1. Define the outcome: strength, training capacity, protein adequacy or convenience.
2. Build the training plan: use suitable progressive resistance exercise and recovery.
3. Review several days of food: include total energy, meal pattern and protein sources.
4. Fill a demonstrated gap: use food or protein powder as appropriate.
5. Consider creatine separately: weigh the small possible additional benefit, uncertainty, cost and health context.
6. Review outcomes: training performance, function, tolerance and whether the original problem was solved.